Study of Tissue and Blood Samples From Patients With High-Grade Glioma - Trial NCT01004887
Access comprehensive clinical trial information for NCT01004887 through Pure Global AI's free database. This phase not specified trial is sponsored by Alliance for Clinical Trials in Oncology and is currently Completed. The study focuses on Brain and Central Nervous System Tumors. Target enrollment is 631 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Alliance for Clinical Trials in Oncology
Timeline & Enrollment
N/A
Nov 01, 1995
Jan 15, 2019
Primary Outcome
time to progression,survival
Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the
 laboratory may help doctors learn more about changes that occur in DNA and identify
 biomarkers related to cancer. It may also help doctors predict how patients will respond to
 treatment.
 
 PURPOSE: This research study is looking at tissue and blood samples from patients with
 high-grade glioma.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01004887
Non-Device Trial